To test the effect of APOA1 mimetic peptides (D-4F, L-4F, and L-5F) in ovarian cancer, cell lines and mouse models were administered the peptides; this study reported a significant decrease in the serum lysophosphatidic acid levels and reduced ovarian cancer cell growth and proliferation [199,200,201]. Here, APOA1 is linked to ovarian carcinoma.